Global Mycoplasma Hyopneumoniae Vaccine Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Mycoplasma Hyopneumoniae Vaccine Consumption 2016-2026

2.1.2 Mycoplasma Hyopneumoniae Vaccine Consumption CAGR by Region

2.2 Mycoplasma Hyopneumoniae Vaccine Segment by Type

2.2.1 Live

2.2.2 Inactivated

2.3 Mycoplasma Hyopneumoniae Vaccine Sales by Type

2.3.1 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Type (2016-2021)

2.4 Mycoplasma Hyopneumoniae Vaccine Segment by Application

2.4.1 Piglets

2.4.2 Adult Pigs

2.5 Mycoplasma Hyopneumoniae Vaccine Sales by Application

2.5.1 Global Mycoplasma Hyopneumoniae Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Application (2016-2021)

3 Global Mycoplasma Hyopneumoniae Vaccine by Company

3.1 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Company

3.1.1 Global Mycoplasma Hyopneumoniae Vaccine Sales by Company (2019-2021)

3.1.2 Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company

3.2.1 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Company (2019-2021)

3.2.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Company

3.4 Global Manufacturers Mycoplasma Hyopneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Mycoplasma Hyopneumoniae Vaccine Product Location Distribution

3.4.2 Players Mycoplasma Hyopneumoniae Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Mycoplasma Hyopneumoniae Vaccine by Region

4.1 Global Mycoplasma Hyopneumoniae Vaccine by Region

4.1.1 Global Mycoplasma Hyopneumoniae Vaccine Sales by Region

4.1.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region

4.2 Americas Mycoplasma Hyopneumoniae Vaccine Sales Growth

4.3 APAC Mycoplasma Hyopneumoniae Vaccine Sales Growth

4.4 Europe Mycoplasma Hyopneumoniae Vaccine Sales Growth

4.5 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Growth

5 Americas

5.1 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Country

5.1.1 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021)

5.1.2 Americas Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021)

5.2 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Type

5.3 Americas Mycoplasma Hyopneumoniae Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Region

6.1.1 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Region (2016-2021)

6.1.2 APAC Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2016-2021)

6.2 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Type

6.3 APAC Mycoplasma Hyopneumoniae Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Mycoplasma Hyopneumoniae Vaccine by Country

7.1.1 Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021)

7.1.2 Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021)

7.2 Europe Mycoplasma Hyopneumoniae Vaccine Sales by Type

7.3 Europe Mycoplasma Hyopneumoniae Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine by Country

8.1.1 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Type

8.3 Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Mycoplasma Hyopneumoniae Vaccine Distributors

10.3 Mycoplasma Hyopneumoniae Vaccine Customer

11 Global Mycoplasma Hyopneumoniae Vaccine Market Forecast

11.1 Global Mycoplasma Hyopneumoniae Vaccine Forecast by Region

11.1.1 Global Mycoplasma Hyopneumoniae Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Mycoplasma Hyopneumoniae Vaccine Forecast by Type

11.7 Global Mycoplasma Hyopneumoniae Vaccine Forecast by Application

12 Key Players Analysis

12.1 Zoetis

12.1.1 Zoetis Company Information

12.1.2 Zoetis Mycoplasma Hyopneumoniae Vaccine Product Offered

12.1.3 Zoetis Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Zoetis Main Business Overview

12.1.5 Zoetis Latest Developments

12.2 Merck

12.2.1 Merck Company Information

12.2.2 Merck Mycoplasma Hyopneumoniae Vaccine Product Offered

12.2.3 Merck Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Merck Main Business Overview

12.2.5 Merck Latest Developments

12.3 Boehringer Ingelheim

12.3.1 Boehringer Ingelheim Company Information

12.3.2 Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Product Offered

12.3.3 Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Boehringer Ingelheim Main Business Overview

12.3.5 Boehringer Ingelheim Latest Developments

12.4 Ceva Santé Animale

12.4.1 Ceva Santé Animale Company Information

12.4.2 Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Product Offered

12.4.3 Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Ceva Santé Animale Main Business Overview

12.4.5 Ceva Santé Animale Latest Developments

12.5 Elanco Animal Health

12.5.1 Elanco Animal Health Company Information

12.5.2 Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

12.5.3 Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Elanco Animal Health Main Business Overview

12.5.5 Elanco Animal Health Latest Developments

12.6 Qilu Animal Health

12.6.1 Qilu Animal Health Company Information

12.6.2 Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

12.6.3 Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Qilu Animal Health Main Business Overview

12.6.5 Qilu Animal Health Latest Developments

12.7 Ruipu

12.7.1 Ruipu Company Information

12.7.2 Ruipu Mycoplasma Hyopneumoniae Vaccine Product Offered

12.7.3 Ruipu Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Ruipu Main Business Overview

12.7.5 Ruipu Latest Developments

12.8 Shanghai Hile Bio-Technology Co., Ltd.

12.8.1 Shanghai Hile Bio-Technology Co., Ltd. Company Information

12.8.2 Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Product Offered

12.8.3 Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Shanghai Hile Bio-Technology Co., Ltd. Main Business Overview

12.8.5 Shanghai Hile Bio-Technology Co., Ltd. Latest Developments

12.9 CAHIC

12.9.1 CAHIC Company Information

12.9.2 CAHIC Mycoplasma Hyopneumoniae Vaccine Product Offered

12.9.3 CAHIC Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 CAHIC Main Business Overview

12.9.5 CAHIC Latest Developments

12.10 Pulike

12.10.1 Pulike Company Information

12.10.2 Pulike Mycoplasma Hyopneumoniae Vaccine Product Offered

12.10.3 Pulike Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Pulike Main Business Overview

12.10.5 Pulike Latest Developments

12.11 Harbin Pharmaceutical Group

12.11.1 Harbin Pharmaceutical Group Company Information

12.11.2 Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Product Offered

12.11.3 Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Harbin Pharmaceutical Group Main Business Overview

12.11.5 Harbin Pharmaceutical Group Latest Developments

13 Research Findings and Conclusion

Table 1. Mycoplasma Hyopneumoniae Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Live

Table 3. Major Players of Inactivated

Table 4. Global Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units)

Table 5. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021)

Table 6. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2016-2021) & ($ million)

Table 7. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2016-2021)

Table 8. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Type (2016-2021)

Table 9. Global Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units)

Table 10. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021)

Table 11. Global Mycoplasma Hyopneumoniae Vaccine Value by Application (2016-2021)

Table 12. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2016-2021)

Table 13. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Application (2016-2021)

Table 14. Global Mycoplasma Hyopneumoniae Vaccine Sales by Company (2019-2021) & (K Units)

Table 15. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Company (2019-2021)

Table 16. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company (2019-2021)

Table 18. Global Mycoplasma Hyopneumoniae Vaccine Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Mycoplasma Hyopneumoniae Vaccine Producing Area Distribution and Sales Area

Table 20. Players Mycoplasma Hyopneumoniae Vaccine Products Offered

Table 21. Mycoplasma Hyopneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Mycoplasma Hyopneumoniae Vaccine Sales by Region (2016-2021) (K Units)

Table 25. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2016-2021)

Table 26. Global Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2016-2021)

Table 28. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021) & (K Units)

Table 29. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2016-2021)

Table 30. Americas Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2016-2021)

Table 32. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units)

Table 33. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021)

Table 34. Americas Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units)

Table 35. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021)

Table 36. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Region (2016-2021) & (K Units)

Table 37. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2016-2021)

Table 38. APAC Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2016-2021)

Table 40. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units)

Table 41. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021)

Table 42. APAC Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units)

Table 43. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021)

Table 44. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021) & (K Units)

Table 45. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2016-2021)

Table 46. Europe Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2016-2021)

Table 48. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units)

Table 49. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021)

Table 50. Europe Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units)

Table 51. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Mycoplasma Hyopneumoniae Vaccine

Table 61. Key Application and Potential Industries of Mycoplasma Hyopneumoniae Vaccine

Table 62. Key Challenges of Mycoplasma Hyopneumoniae Vaccine

Table 63. Key Trends of Mycoplasma Hyopneumoniae Vaccine

Table 64. Mycoplasma Hyopneumoniae Vaccine Distributors List

Table 65. Mycoplasma Hyopneumoniae Vaccine Customer List

Table 66. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Mycoplasma Hyopneumoniae Vaccine Consumption Market Forecast by Region

Table 68. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Mycoplasma Hyopneumoniae Vaccine Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Mycoplasma Hyopneumoniae Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 86. Zoetis Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 87. Zoetis Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 88. Zoetis Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Zoetis Main Business

Table 90. Zoetis Latest Developments

Table 91. Merck Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 92. Merck Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 93. Merck Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Merck Main Business

Table 95. Merck Latest Developments

Table 96. Boehringer Ingelheim Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 97. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 98. Boehringer Ingelheim Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. Boehringer Ingelheim Main Business

Table 100. Boehringer Ingelheim Latest Developments

Table 101. Ceva Santé Animale Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 102. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 103. Ceva Santé Animale Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Ceva Santé Animale Main Business

Table 105. Ceva Santé Animale Latest Developments

Table 106. Elanco Animal Health Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 107. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 108. Elanco Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Elanco Animal Health Main Business

Table 110. Elanco Animal Health Latest Developments

Table 111. Qilu Animal Health Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 112. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 113. Qilu Animal Health Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. Qilu Animal Health Main Business

Table 115. Qilu Animal Health Latest Developments

Table 116. Ruipu Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 117. Ruipu Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 118. Ruipu Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. Ruipu Main Business

Table 120. Ruipu Latest Developments

Table 121. Shanghai Hile Bio-Technology Co., Ltd. Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 122. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 123. Shanghai Hile Bio-Technology Co., Ltd. Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. Shanghai Hile Bio-Technology Co., Ltd. Main Business

Table 125. Shanghai Hile Bio-Technology Co., Ltd. Latest Developments

Table 126. CAHIC Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 127. CAHIC Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 128. CAHIC Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. CAHIC Main Business

Table 130. CAHIC Latest Developments

Table 131. Pulike Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 132. Pulike Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 133. Pulike Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. Pulike Main Business

Table 135. Pulike Latest Developments

Table 136. Harbin Pharmaceutical Group Basic Information, Mycoplasma Hyopneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 137. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Product Offered

Table 138. Harbin Pharmaceutical Group Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 139. Harbin Pharmaceutical Group Main Business

Table 140. Harbin Pharmaceutical Group Latest Developments

List of Figures

Figure 1. Picture of Mycoplasma Hyopneumoniae Vaccine

Figure 2. Mycoplasma Hyopneumoniae Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Mycoplasma Hyopneumoniae Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Live

Figure 10. Product Picture of Inactivated

Figure 11. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020

Figure 12. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2016-2021)

Figure 13. Mycoplasma Hyopneumoniae Vaccine Consumed in Piglets

Figure 14. Global Mycoplasma Hyopneumoniae Vaccine Market: Piglets (2016-2021) & (K Units)

Figure 15. Mycoplasma Hyopneumoniae Vaccine Consumed in Adult Pigs

Figure 16. Global Mycoplasma Hyopneumoniae Vaccine Market: Adult Pigs (2016-2021) & (K Units)

Figure 17. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2016-2021)

Figure 18. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application in 2020

Figure 19. Mycoplasma Hyopneumoniae Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 20. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Company in 2020

Figure 21. Global Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Regions (2016-2021)

Figure 22. Global Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region in 2020

Figure 23. Americas Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units)

Figure 24. Americas Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions)

Figure 25. APAC Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units)

Figure 26. APAC Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions)

Figure 27. Europe Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units)

Figure 28. Europe Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions)

Figure 29. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales 2016-2021 (K Units)

Figure 30. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue 2016-2021 ($ Millions)

Figure 31. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2020

Figure 32. Americas Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2020

Figure 33. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020

Figure 34. Americas Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020

Figure 35. United States Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 36. Canada Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 37. Mexico Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Brazil Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region in 2020

Figure 40. APAC Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Regions in 2020

Figure 41. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020

Figure 42. APAC Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020

Figure 43. China Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 44. Japan Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 45. Korea Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Southeast Asia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. India Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. Australia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2020

Figure 50. Europe Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2020

Figure 51. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020

Figure 52. Europe Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020

Figure 53. Germany Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 54. France Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 55. UK Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. Italy Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. Russia Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country in 2020

Figure 59. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Country in 2020

Figure 60. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type in 2020

Figure 61. Middle East & Africa Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application in 2020

Figure 62. Egypt Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 63. South Africa Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 64. Israel Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. Turkey Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. GCC Country Mycoplasma Hyopneumoniae Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles